The treatment of CRC cell lines with anti-methylation drug DAC could significantly increase the expression of GFRA1 (S1C–S1E Fig), this indicates that GFRA1 expression could be upregulated by GFRA1 demethylation. Here, GFRA1 is linked to colorectal carcinoma.